AI assistant
BELDEN INC. — Director's Dealing 2025
Feb 26, 2025
31053_dirs_2025-02-25_bcb0986a-5bd1-46be-980b-1e6a6ef492af.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BELDEN INC. (BDC)
CIK: 0000913142
Period of Report: 2025-02-21
Reporting Person: Tate Leah (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-21 | Common Stock | F | 435 | — | Disposed | 22808 | Direct |
| 2025-02-24 | Common Stock | F | 241 | — | Disposed | 22567 | Direct |
| 2025-02-24 | Common Stock | M | 441 | $53.79 | Acquired | 23008 | Direct |
| 2025-02-24 | Common Stock | D | 277 | $111.09 | Disposed | 22731 | Direct |
| 2025-02-25 | Common Stock | S | 164 | $111.76 | Disposed | 22567 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | Stock Appreciation Rights | $53.79 | M | 441 | Disposed | 2032-02-22 | Common Stock (441) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3360 | Indirect |
| Common Stock | 1030.1076 | Indirect |
Footnotes
F1: Shares withheld for tax purposes related to portion of February 21, 2024 restricted stock unit grant that vested on February 21, 2025.
F2: Shares withheld for tax purposes related to February 22, 2022 restricted stock unit grant that vested on February 24, 2025.
F3: Represents the balance of shares of Belden Inc. common stock held in the Belden Retirement Savings Plan as of the date of this filing.
F4: The exercise reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.
F5: This represents the difference between the number of SARs exercised (441) and the number of shares issued as a result of the exercise (164). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the FMV on the date of exercise ($111.09) and the exercise price ($53.79). Additional shares were then withheld to satisfy the Company's tax withholding obligations.
F6: The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by Ms. Tate on November 8, 2024.